BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30335941)

  • 1. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation.
    Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M
    ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: Application of central composite design, thermal analysis and X-ray diffraction techniques.
    Behbahani ES; Ghaedi M; Abbaspour M; Rostamizadeh K
    Ultrason Sonochem; 2017 Sep; 38():271-280. PubMed ID: 28633826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
    Madane RG; Mahajan HS
    Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
    Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
    Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
    Singh A; Neupane YR; Mangla B; Kohli K
    J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
    Shehata MK; Ismail AA; Kamel MA
    Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
    Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
    AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
    Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
    Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.